GNPX GENPREX INC Management Changes 8-K Filing 2024 - Resignation and Clinical Study Update Genprex announces the resignation of Catherine Vaczy and provides updates on the Phase 2a expansion portion of the Acclaim-1 clinical study of Reqorsa Therapy.Get access to all SEC 8-K filings of the GENPREX INC